相似文献
1
Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic.
Thorax. 1992 Jan;47(1):30-3. doi: 10.1136/thx.47.1.30.
2
Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
Thorax. 2001 Jul;56(7):529-35. doi: 10.1136/thorax.56.7.529.
3
Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.
Thorax. 1993 Jun;48(6):611-4. doi: 10.1136/thx.48.6.611.
4
Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
J Allergy Clin Immunol. 1989 Dec;84(6 Pt 1):891-5. doi: 10.1016/0091-6749(89)90385-0.
5
Onset and duration of action of single doses of formoterol inhaled via Turbuhaler.
Respir Med. 1998 Aug;92(8):1017-21. doi: 10.1016/s0954-6111(98)90348-1.
6
A study of the duration of the bronchodilator effect of 12 micrograms and 24 micrograms of inhaled formoterol and 200 micrograms inhaled salbutamol in asthma.
Respir Med. 1990 Mar;84(2):135-8. doi: 10.1016/s0954-6111(08)80016-9.
7
Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.
Allergy. 1995 Aug;50(8):657-63. doi: 10.1111/j.1398-9995.1995.tb02582.x.
8
Objective and subjective bronchodilation over 12 hours after inhaled formoterol: individual responses.
J Asthma. 1993;30(6):459-65. doi: 10.3109/02770909309056755.
9
Formoterol, a new long-acting selective beta 2-agonist, decreases airway responsiveness in children with asthma.
Lung. 1990;168 Suppl:99-102. doi: 10.1007/BF02718120.
10
Twelve hours' bronchodilating effect of inhaled formoterol in children with asthma: a double-blind cross-over study versus salbutamol.
Clin Exp Allergy. 1990 Jul;20(4):429-32. doi: 10.1111/j.1365-2222.1990.tb02805.x.
引用本文的文献
1
Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis.
Cochrane Database Syst Rev. 2023 Aug 21;8(8):CD013797. doi: 10.1002/14651858.CD013797.pub2.
2
Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis.
Cochrane Database Syst Rev. 2022 Dec 6;12(12):CD013799. doi: 10.1002/14651858.CD013799.pub2.
3
How does race and ethnicity effect the precision treatment of asthma?
Expert Rev Precis Med Drug Dev. 2019;4(6):337-356. doi: 10.1080/23808993.2019.1690396. Epub 2019 Nov 14.
4
Regional airflow obstruction after bronchoconstriction and subsequent bronchodilation in subjects without pulmonary disease.
J Appl Physiol (1985). 2019 Jul 1;127(1):31-39. doi: 10.1152/japplphysiol.00912.2018. Epub 2019 May 23.
5
Comparison of the effectiveness and safety of formoterol versus salmeterol in the treatment of patients with asthma: A systematic review and meta-analysis.
J Res Med Sci. 2015 May;20(5):483-90. doi: 10.4103/1735-1995.163974.
6
Human airway contraction and formoterol-induced relaxation is determined by Ca2+ oscillations and Ca2+ sensitivity.
Am J Respir Cell Mol Biol. 2010 Aug;43(2):179-91. doi: 10.1165/rcmb.2009-0222OC. Epub 2009 Sep 18.
7
Comparison of the Bronchodilator Effect of Inhaled Short- and Long-Acting beta(2)-Agonists in Children with Bronchial Asthma: A Randomised Trial.
Clin Drug Investig. 1998;16(1):19-24. doi: 10.2165/00044011-199816010-00003.
8
Hypokalaemia in healthy volunteers after single and multiple doses of formoterol or salbutamol.
Clin Drug Investig. 1998;15(6):523-9. doi: 10.2165/00044011-199815060-00009.
9
Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Drugs. 2006;66(17):2235-54. doi: 10.2165/00003495-200666170-00006.
10
Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
Br J Clin Pharmacol. 2004 Oct;58(4):359-66. doi: 10.1111/j.1365-2125.2004.02172.x.
本文引用的文献
1
Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma.
J Allergy Clin Immunol. 1987 Jan;79(1):78-85. doi: 10.1016/s0091-6749(87)80020-9.
2
Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.
Allergy. 1989 May;44(4):264-71. doi: 10.1111/j.1398-9995.1989.tb01068.x.
3
Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours.
Chest. 1990 Mar;97(3):590-4. doi: 10.1378/chest.97.3.590.
4
Bronchoconstrictor effects of a deep inspiration in patients with asthma.
Am Rev Respir Dis. 1975 Apr;111(4):433-9. doi: 10.1164/arrd.1975.111.4.433.
Zotero 插件